An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Multiple molecular profiling methods are required to study urothelial non-muscle-invasive bladder cancer (NMIBC) due to its heterogeneity. Here the authors integrate multi-omics data of 834 NMIBC patients, identifying a molecular subgroup associated with multiple alterations and worse outcomes.
Saved in:
Similar Items
-
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
by: Ann Taber, et al.
Published: (2020) -
Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
by: Ann Taber, et al.
Published: (2021) -
Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p.
by: Pontus Eriksson, et al.
Published: (2013) -
Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.
by: Moniek M Vedder, et al.
Published: (2014) -
Impact of Sediment Layer on Longitudinal Dispersion in Sewer Systems
by: Marek Sokáč, et al.
Published: (2021)